Loading...
Kamada Ltd.
KMDA•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$7.72
$-0.06(-0.77%)
Kamada Ltd. (KMDA) Financial Performance & Income Statement Overview
Review Kamada Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
12.93%
↑ 12.93%
Operating Income Growth
99.23%
↑ 99.23%
Net Income Growth
74.58%
↑ 74.58%
Operating Cash Flow Growth
1002.99%
↑ 1002.99%
Operating Margin
14.29%
↑ 14.29%
Gross Margin
44.23%
↑ 44.23%
Net Profit Margin
9.64%
↑ 9.64%
ROE
6.32%
↑ 6.32%
ROIC
7.49%
↑ 7.49%
Kamada Ltd. (KMDA) Income Statement & Financial Overview
Review Kamada Ltd.'s (KMDA) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $39.005M | $41.74M | $41.88M | $37.40M |
| Cost of Revenue | $21.97M | $24.51M | $23.19M | $20.80M |
| Gross Profit | $17.03M | $17.23M | $18.69M | $16.60M |
| Gross Profit Ratio | $0.44 | $0.41 | $0.45 | $0.44 |
| R&D Expenses | $2.72M | $3.41M | $4.80M | $4.26M |
| SG&A Expenses | $5.39M | $8.52M | $8.51M | $8.34M |
| Operating Expenses | $11.95M | $11.94M | $13.31M | $12.60M |
| Total Costs & Expenses | $33.93M | $36.45M | $36.83M | $33.40M |
| Interest Income | $684000.00 | $646000.00 | $508000.00 | $280000.00 |
| Interest Expense | $189000.00 | $167000.00 | $145000.00 | $159000.00 |
| Depreciation & Amortization | $4.10M | $3.24M | $3.23M | $3.21M |
| EBITDA | $6.86M | $7.36M | $8.87M | $5.78M |
| EBITDA Ratio | $0.18 | $0.18 | $0.21 | $0.15 |
| Operating Income | $5.08M | $5.29M | $5.64M | $4.003M |
| Operating Income Ratio | $0.13 | $0.13 | $0.13 | $0.11 |
| Other Income/Expenses (Net) | -$2.62M | -$1.35M | -$1.15M | -$1.62M |
| Income Before Tax | $2.46M | $3.95M | $4.49M | $2.42M |
| Income Before Tax Ratio | $0.06 | $0.09 | $0.11 | $0.06 |
| Income Tax Expense | -$1.35M | $84000.00 | $63000.00 | $73337.00 |
| Net Income | $3.81M | $3.86M | $4.43M | $2.37M |
| Net Income Ratio | $0.10 | $0.09 | $0.11 | $0.06 |
| EPS | $0.07 | $0.07 | $0.08 | $0.04 |
| Diluted EPS | $0.07 | $0.07 | $0.08 | $0.04 |
| Weighted Avg Shares Outstanding | $54.40M | $55.19M | $55.33M | $57.47M |
| Weighted Avg Shares Outstanding (Diluted) | $54.40M | $55.19M | $55.33M | $57.47M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan